ESPERITE (ESP) will oppose the decision of the AFM and object to the fine.
February 24, 2020
Group News
24 February 2020
***
24 February 2020
***
18 February 2020
***
17 February 2020
Esperite update the market
Esperite NV (Esperite, The Company) updates its shareholders on the current configuration and business of the company.
***
Amsterdam, The Netherlands – 13 February 2020
***
Press Release : EGM-26-March-2020-Press-Release-1.pdf
Agenda : EGM-26-March-2020-Agenda-1.pdf
Notice : EGM-26-March-2020-Notice-1.pdf
Explanatory Notes : EGM-26-March-2020-Explanatory-Notes-1.pdf
Power of Attorney : EGM-26-March-2020-Power-of-Attorney-1.pdf
ESPERITE N.V: Samples and Database are safe. The recent articles published about CryoSave on loss of samples are poorly informed and defamatory.
Amsterdam, The Netherlands – 10 February 2020
***
ESPERITE (ESP) is not bankrupt.
Amsterdam, The Netherlands – 30 October 2019
***
This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).
ESPERITE (ESP) disputes the Court verdict and appeals the order.
Amsterdam, The Netherlands – 14 October 2019
To learn more about the ESPERITE Group, info@esperitegroup.com or visit the website at www.esperite.com,
***
This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).
Esperite N.V. (ESP): Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
Amsterdam, The Netherlands – 30 September 2019 read more
CryoSave has maintained without compromise the highquality processing and storage services and has handed over its whole business.
Switzerland – 19 September 2019
read more
ESPERITE NV AND MYRISOPH CAPITAL CONCLUDE A STRATEGIC AGREEMENT ON CRYO-SAVE’S FAMILY STEM CELL BANKING BUSINESS
Amsterdam, The Netherlands – 27 August 2019
read more
